Clinical Trials Browser

Completed × INDUSTRY × sirtratumab vedotin × Clear all

NCT01963052 2024-11-01

ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer

Phase 1 Completed

Metastatic Urothelial Cancer